Sisram Medical Ltd (HKG:1696)

Market Cap	2.75B
Revenue (ttm)	2.71B
Net Income (ttm)	161.71M
Shares Out	468.34M
EPS (ttm)	0.34
PE Ratio	17.06
Forward PE	8.68
Dividend	0.13 (2.14%)
Ex-Dividend Date	Aug 26, 2025

Volume	3,267,600
Average Volume	2,604,192
Open	6.06
Previous Close	6.03
Day's Range	5.69 - 6.06
52-Week Range	2.75 - 8.07
Beta	1.15
RSI	47.68
Earnings Date	Aug 19, 2025

About Sisram Medical

Sisram Medical Ltd engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home use devices, injectables, and cosmeceuticals products in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio for various wellness businesses, including hair growth and removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 1,015
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1696

Financial Performance

In 2024, Sisram Medical's revenue was $349.11 million, a decrease of -2.83% compared to the previous year's $359.29 million. Earnings were $25.13 million, a decrease of -20.23%.

Financial numbers in USD